Skip to main content
Log in

Serum Levels of α1-Antitrypsin Predict Phenotypic Expression of the α1-Antitrypsin Gene

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We conducted a retrospective analysis to determine if both α1-antitrypsin serum level and phenotype need be studied when evaluating children for α1-AT deficiency. We collected data from patients less than 19 years old who had both serum α1-AT level and phenotype determined over a 9-year period (January 1992–December 2000). Eighty-eight patients were identified and 15 had the PiZZ phenotype. The serum α1-AT level was below normal (normal 85–215 mg/dl) in all 15 PiZZ patients. Seventy-two of 73 non-PiZZ patients had normal or above normal serum levels. The sensitivity of the serum α1-AT level was 100%, and the specificity was 99%. The serum α1-AT level had a positive predictive value of 94% and a negative predictive value of 100%. We conclude that serum α1-AT levels are highly predictive of the PiZZ phenotype. Determination of the serum α1-AT level alone should be the initial test when evaluating for α1-AT deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Teckman JH, Qu D, Perlmutter DH: Molecular pathogenesis of liver disease in α1-antitrypsin deficiency. Hepatology 24:1504–1516, 1996

    Google Scholar 

  2. Norman MR, Mowat AP, Hutchison DCS: Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency. Ann Clin Biochem 34:230–246, 1997

    Google Scholar 

  3. Carrell RW, Lomas DA: Alpha1-antitrypsin deficiency—a model for conformational diseases. N Engl J Med 346:45–53, 2002

    Google Scholar 

  4. Sveger T: The natural history of liver disease in α1-antitrypsin deficient children. Acta Paediatr Scand 77:847–851, 1988

    Google Scholar 

  5. Larsson C: Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204:345–351, 1978

    Google Scholar 

  6. Sveger T: Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294:1316–1321, 1976

    Google Scholar 

  7. O'Brien ML, Buist NRM, Murphey WH: Neonatal screening for alpha1-antitrypsin deficiency. J Pediatr 92:1006–1010, 1978

    Google Scholar 

  8. Silverman EK, Miletich JP, Pierce JA, Sherman LA, Endicott SK, Broze GJ Jr, Campbell EJ: Alpha-1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 140:961–966, 1989

    Google Scholar 

  9. Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG: Risk factors for emphysema: cigarette smoking is associated with a reduction in the association rate constant of lung α1-antitrypsin for neutrophil elastase. J Clin Invest 87:1060–1065, 1991

    Google Scholar 

  10. Buist AS, Burrows B, Cohen A, Crystal RG, Fallat RJ, Gadek JE, Turino GM: Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am Rev Respir Dis 140:1494–1497, 1989

    Google Scholar 

  11. Primhak RA, Tanner MS: Alpha-1 antitrypsin deficiency. Arch Dis Child 85:2–5, 2001

    Google Scholar 

  12. Ward AM, Cooper EH, Turner R, Anderson JA, Neville AM: Acute-phase reactant protein profiles: An aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer 35:170–178, 1977

    Google Scholar 

  13. Lamy Y, Ibrahim S, Lomanto C, Dombrowiecki A: Sequential changes of α1-antitrypsin after surgical trauma. Clin Chim Acta 89:387–391, 1978

    Google Scholar 

  14. Child JA, Roberts BE, Illingworth S, Cooper EH: Acute phase reactant proteins in chronic leukaemia. Biomedicine 27:188–190, 1977

    Google Scholar 

  15. Beyeler C, Banks RE, Bird HA: Polymorphonuclear elastase-α1-proteinase inhibitor (elastase-α1 antitrypsin) in patients with rheumatic diseases: Influence of disease activity. J Rheumatol 27:15–19, 2000

    Google Scholar 

  16. Carlson J, Eriksson S: α1-antitrypsin and other acute phase reactants in liver disease. Acta Med Scand 207:79–83, 1980

    Google Scholar 

  17. El-Kassimi FA, Warsy AS, Uz-Zaman A, Pillai DK: Alpha 1-antitrypsin serum levels in widespread bronchiectasis. Respir Med 83:119–121, 1989

    Google Scholar 

  18. Sharp HL, Bridges RA, Krivit W, Freier EF: Cirrhosis associated with alpha-1-antitrypsin deficiency: A previously unrecognized inherited disorder. J Lab Clin Med 73:934–939, 1969

    Google Scholar 

  19. Lieberman J, Mittman C: Dynamic response of α1-antitrypsin variants to diethylstilbestrol. Am J Hum Genet 25:610–617, 1973

    Google Scholar 

  20. Gadek JE, Fulmer JD, Gelfand JA, Frank MM, Petty TL, Crystal RG: Danazol-induced augmentation of serum α1-antitrypsin levels in individuals with marked deficiency of this antiprotease. J Clin Invest 66:82–87, 1980

    Google Scholar 

  21. Wewers MD, Gadek JE, Keogh BA, Fells GA, Crystal RG: Evaluation of danazol therapy for patients with PiZZ alpha-1-antitrypsin deficiency. Am Rev Respir Dis 134:476–480, 1986

    Google Scholar 

  22. Wewers MD, Brantly ML, Casolaro MA, Crystal RG: Evaluation of tamoxifen as a therapy to augment alpha-1-antitrypsin concentrations in Z homozygous alpha-1-antitrypsin-deficient subjects. Am Rev Respir Dis 135:401–402, 1987

    Google Scholar 

  23. Brantly ML, Wittes JT, Vogelmeier CF, Hubbard RC, Fells GA, Crystal RG: Use of a highly purified α1-antitrypsin standard to establish ranges for the common normal and deficient α1-antitrypsin phenotypes. Chest 100:703–708, 1991

    Google Scholar 

  24. Fagerhol MK: The genetics of alpha-1-antitrypsin and its implications. Postgrad Med J 52 Suppl 2:73–83, 1976

    Google Scholar 

  25. Turino GM, Barker AF, Brantly ML, Cohen AM, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK: Clinical features of individuals with Pi*SZ phenotype of α1-antitrypsin deficiency. Am J Respir Crit Care Med 154:1718–1725, 1996

    Google Scholar 

  26. Odievre M, Martin J-P, Hadchouel M, Alagille D: Alpha1-antitrypsin deficiency and liver disease in children: phenotypes, manifestations, and prognosis. Pediatrics 57:226–231, 1976

    Google Scholar 

  27. Mahadeva R, Chang WW, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA: Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis. J Clin Invest 103:999–1006, 1999

    Google Scholar 

  28. Pittschieler K, Massi G: Liver involvement in infants with PiSZ phenotype of α1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr 15:315–318, 1992

    Google Scholar 

  29. Pittschieler K: Heterozygotes and liver involvement. Acta Paediatr Suppl 393:21–23, 1994

    Google Scholar 

  30. Bell H, Schrumpf E, Fagerhol MK: Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 20:835–842, 1985

    Google Scholar 

  31. Hodges JR, Millward-Sadler GH, Barbatis C, Wright R: Heterozygous MZ alpha1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 304:557–560, 1981

    Google Scholar 

  32. Vecchio FM, Fabiano A, Orsini G, Ragusa D, Massi G: Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion 27:100–104, 1983

    Google Scholar 

  33. Carlson J, Eriksson S: Chronic ‘cryptogenic’ liver disease and malignant hepatoma in intermediate alpha1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. Scand J Gastroenterol 25:788–792, 1990

    Google Scholar 

  34. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W: High prevalence of viral infection in adults with homozygous and heterozygous alpha1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 117:641–645, 1992

    Google Scholar 

  35. Elzouki AN, Hulcrantz R, Stal P, Befrits R, Eriksson S: Increased PiZ gene frequency for α1 antitrypsin in patients with genetic haemochromatosis. Gut 36:922–926, 1995

    Google Scholar 

  36. Vennarecci G, Gunson BK, Ismail T, Hubscher SG, Klly DA, McMaster P, Elias E: Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 61:1488–1495, 1996

    Google Scholar 

  37. Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK: Increased risk of chronic liver failure in adults with heterozygous α1-antitrypsin deficiency. Hepatology 28:1058–1063, 1998

    Google Scholar 

  38. Vaughan L, Lorier MA, Carrell RW: α1-Antitrypsin microheterogeneity isolation and physiological significance of isoforms. Biochim Biophys Acta 701:339–345, 1982

    Google Scholar 

  39. Cook PJL: The genetics of α1-antitrypsin: a family study in England and Scotland. Ann Hum Genet 38:275–287, 1975

    Google Scholar 

  40. Whitehouse DB, Lovegrove JU, Hopkinson DA: Variation in alpha-1-antitrypsin phenotypes with penicillamine therapy. Clin Chim Acta 179:109–116, 1989

    Google Scholar 

  41. Whitehouse DB, Lovegrove JU, Mieli-Vergani G, Mowat AP, Hopkinson DA: 'sZ like' α1-antitrypsin phenotypes in Pi ZZ children with liver disease. Ann Hum Genet 58:11–17, 1994

    Google Scholar 

  42. Attenburrow AA: Modification of the α1-antitrypsin phenotype in neonatal hepatitis. Arch Dis Child 60:378–379, 1985

    Google Scholar 

  43. Sveger T: Screening for alpha1-antitrypsin deficiency. Acta Paediatr Suppl 393:18–20, 1994

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steiner, S.J., Gupta, S.K., Croffie, J.M. et al. Serum Levels of α1-Antitrypsin Predict Phenotypic Expression of the α1-Antitrypsin Gene. Dig Dis Sci 48, 1793–1796 (2003). https://doi.org/10.1023/A:1025411515683

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025411515683

Navigation